Dependency of Tamoxifen Sensitive and Resistant ER(+) Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth

por Bhasin, Satyam, Dusek, Christopher, Peacock, James W., Cherkasov, Artem, Wang, Yuzhuo, Gleave, Martin, Ong, Christopher J.
Publicado 2023

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells

por Yenki, Parvin, Bhasin, Satyam, Liu, Liang, Nabavi, Noushin, Cheng, Chi Wing, Tam, Kevin J, Peacock, James W, Adomat, Hans H, Tombe, Tabitha, Fazli, Ladan, Ivanova, Larissa, Dusek, Christopher, Khosravi, Shahram, Guns, Emma S Tomlinson, Wang, Yuzhuo, Buttyan, Ralph, Gleave, Martin E, Ong, Christopher J
Publicado 2023

Targeting Semaphorin 3C in Prostate Cancer With Small Molecules

por Lee, Chung C W, Munuganti, Ravi Shashi Nayana, Peacock, James W, Dalal, Kush, Jiao, Ivy Z F, Shepherd, Ashley, Liu, Liangliang, Tam, Kevin J, Sedgwick, Colin G, Bhasin, Satyam, Lee, Kevin C K, Gooding, Luke, Vanderkruk, Benjamin, Tombe, Tabitha, Gong, Yifan, Gleave, Martin E, Cherkasov, Artem, Ong, Christopher J
Publicado 2018